Tylenol’s active ingredient linked to language delay for baby girls

Tylenol’s active ingredient linked to language delay for baby girls

Girls born to mothers who took acetaminophen during pregnancy have much higher risk of delay in developing speaking skills

Pregnant women might want to watch their Tylenol use — girls born to mothers who used the pain reliever during pregnancy have higher rates of language delay, according to a new study.


The study is the first to examine mothers' use of Tylenol's active ingredient acetaminophen and babies' ability to learn and speak words at 2 ½ years old and suggests that the pain reliever—the most common drug ingredient in the U.S.—should be used sparingly during pregnancy.

"It's a very important finding, language delay at this age can predict a lot of problems for development and for later in life," said Nicki Bush, an associate professor of psychiatry and pediatrics at the University of California, San Francisco. Bush was not involved in the study.

The findings have big implications: There are more than 600 medicines that contain acetaminophen. Previous studies show almost everyone has acetaminophen in their system, even if they don't take it in medication. The industrial chemical aniline—found in everything from blue jeans to pesticides to personal care products—is converted to acetaminophen in people's livers.

However, pregnant women are more highly exposed—an estimated 65 percent of U.S. women take the drug while pregnant to relieve pain and fevers.

"Given the prevalence of prenatal [acetaminophen] use and the importance of language development, these findings, if replicated, would suggest that pregnant women should limit their use of this analgesic during pregnancy," the authors wrote in the study, published today in the journal European Psychiatry.

The study doesn't prove that acetaminophen spurs language delay in baby girls, however, it builds on previous studies linking the pain reliever to multiple health problems for babies, including altered hormones, reproductive disorders and asthma.

Scientists had 754 Swedish women report their acetaminophen use during pregnancy and tested their urine for the drug. When babies were 30-months old, parents and nurses reported on the baby boys' and girls' ability to speak, defining language delay as those that used fewer than 50 words.

A majority of the women, 59 percent, used the pain reliever. Girls born to mothers who used the drug heavily were almost six times as likely to have a language delay compared to girls whose mothers did not take the drug at all.

Though there were more language delays reported for boys, they didn't see the same association with the drug. "We found that surprising," said senior author of the study Shanna Swan, a professor of reproductive science at Mount Sinai Hospital in New York, who pointed out that previous studies of acetaminophen found more impacts on male reproduction than females.

Swan said it's not clear how the drug may influence a baby's language skills but it's possible that it is via an impact on hormones—specifically androgen, which acetaminophen has been shown to inhibit.

Bush said language delay at 2 ½ years old could spur a "downward spiral" of challenges, including difficulty reading and in school—which is linked to social challenges like rejection from peers, depression and anxiety over school problems, and bad behavior as a way of coping.

And this can all bleed into adulthood. "Educational attainments is linked to earnings, job satisfaction," Bush said.

Swan and colleagues didn't drill down on the reasons for language delay, which can be varied and include hearing or articulation problems, anxiety and autism.

The good news is "language delays have very good responses to early intervention," Bush said.

Researchers will follow the children in the study and check on their language development at 7 years old.

Johnson & Johnson, the parent company of Tylenol, did not respond to requests for comment.

SUBSCRIBE TO EHN'S MUST-READ DAILY NEWSLETTER: ABOVE THE FOLD
Support good science journalism
From our Newsroom
solar power schools

Solar power at Pennsylvania schools doubled during the pandemic

“If this growth continues, schools could set Pennsylvania up as a clean energy leader and not just the fossil fuels we’re known for.”

obesity

Op-Ed: The medical community is missing a major piece of the obesity puzzle

Health care practitioners and regulators need to address the chemicals in everyday products that are in part spurring the obesity crisis.

environmental justice

LISTEN: Black histories and visions of urban planning

We need to center "lived experience and desire in a way that our existing frameworks don't allow for."

ski wax PFAS

Workers exposed to PFAS in a variety of industries

From construction to skiing, PFAS are an important, but understudied, source of on-the-job chemical exposure.

PFAS Testing

Investigation: PFAS on our shelves and in our bodies

Testing finds concerning chemicals in everything from sports bras to ketchup, including in brands labeled PFAS-free.

1872 mining law

Peter Dykstra: The steal of the last century and a half

The General Mining Law of 1872 turned 150 this month. It hasn’t changed a bit.

Stay informed: sign up for Above the Fold
The most consequential news on your health and the planet: delivered to your inbox every morning. (Weekly roundup also available)